SPRY vs WMT · rev $89.1M vs P/E 42, rev $713.16B
ARS Pharmaceuticals, Inc (SPRY) versus Walmart Inc (WMT) — a side-by-side from cached financials, not a winner call.
ARS Pharmaceuticals, Inc (SPRY) is a biotechnology company listed on NASDAQ.
Walmart Inc (WMT) is a discount stores company listed on US. It is led by Doug McMillon.
Latest reported SPRY revenue for 2024-12-31 was $89.1M. Net income was $8.0M. Revenue was up 297063.3% from 2023-12-31 to 2024-12-31. SPRY currently screens at market cap $983.1M.
Latest reported WMT revenue for 2026-01-31 was $713.16B. Net income was $21.89B. Revenue was up 4.7% from 2025-01-31 to 2026-01-31. WMT currently screens at market cap $780.33B and trailing P/E 41.8.
SPRY currently screens at market cap $983.1M. WMT currently screens at market cap $780.33B and trailing P/E 41.8.
Not investment advice. Open the SPRY and WMT stock pages for the full models.
Not investment advice.